MIR6794

Across TCGA pan-cancer cohorts, MIR6794 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR6794 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher MIR6794 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6794 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

ESCA, SKCM, and HNSC are the cancer types where MIR6794 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	All	0.099	0.536	<.001	99	view →
SKCM	DFS	Tertile	II,III,IV	0.134	0.683	.008	18	view →
HNSC	DFS	Tertile	All	1.000	0.596	.031	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MIR6794–ESCA (DFS)

Open the ESCA breakdown →